IN2013MU02208A - - Google Patents

Download PDF

Info

Publication number
IN2013MU02208A
IN2013MU02208A IN2208MU2013A IN2013MU02208A IN 2013MU02208 A IN2013MU02208 A IN 2013MU02208A IN 2208MU2013 A IN2208MU2013 A IN 2208MU2013A IN 2013MU02208 A IN2013MU02208 A IN 2013MU02208A
Authority
IN
India
Prior art keywords
fixed dose
relates
antiflatulents
pharmaceutical compositions
present
Prior art date
Application number
Other languages
English (en)
Inventor
Vijay Patil
Ragini Singh
Venugopal PRABHAKARAN
Shajahan Mohamed MUSTHABA
Selvaraj SEKAR
Stefanie Krenzlin
Original Assignee
Abbott India Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott India Ltd filed Critical Abbott India Ltd
Priority to IN2208MU2013 priority Critical patent/IN2013MU02208A/en
Publication of IN2013MU02208A publication Critical patent/IN2013MU02208A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN2208MU2013 2013-06-29 2013-06-29 IN2013MU02208A (hu)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN2208MU2013 IN2013MU02208A (hu) 2013-06-29 2013-06-29

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2208MU2013 IN2013MU02208A (hu) 2013-06-29 2013-06-29

Publications (1)

Publication Number Publication Date
IN2013MU02208A true IN2013MU02208A (hu) 2015-06-12

Family

ID=54396464

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2208MU2013 IN2013MU02208A (hu) 2013-06-29 2013-06-29

Country Status (1)

Country Link
IN (1) IN2013MU02208A (hu)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023152674A1 (en) 2022-02-09 2023-08-17 Berlia Sushma Paul A pharmaceutical combination of antispasmodic and anxiolytic agent

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023152674A1 (en) 2022-02-09 2023-08-17 Berlia Sushma Paul A pharmaceutical combination of antispasmodic and anxiolytic agent

Similar Documents

Publication Publication Date Title
IL283760A (en) Preparations containing dextromethorphan and bupropion or similar substances and their uses
PH12019500176A1 (en) Heterocyclic compounds and ther uses
HK1226301A1 (zh) 修飾的治療劑及其組合物
MX2015008999A (es) Inhibidores mk2 y usos de los mismos.
HK1212207A1 (en) Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith
IL246252A0 (en) Diaminopyrimidyl derivative compounds, their compositions and methods of treatment
PH12016501122A1 (en) Delayed release compositions of linaclotide
EP2990405A4 (en) DEUTERATED DIAMINOPYRIMIDINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS WITH SUCH COMPOUNDS
MX2020001756A (es) Compuestos deuterados del inhibidor vmat y el uso de dichos compuestos.
HK1222398A1 (zh) 治療伯克霍爾德氏菌感染症的組合物及方法
SG10201902326XA (en) Mk2 inhibitors and uses thereof
IN2015DN00127A (hu)
MX2016004556A (es) Composicion de hueso comprimido y metodo para usar la misma.
PL3065732T3 (pl) Związki, kompozycje i odpowiednie zastosowania do zapobiegania i/lub leczenia dyslipidemii
IL251120B (en) Immunogenic/therapeutic glycoside preparations and their uses
IN2013MU03641A (hu)
PH12017500348B1 (en) Tetrahydroquinoline derivatives as bromodomain inhibitors
HK1220374A1 (zh) 用於治療碳氧血紅蛋白血症的組合物和方法
MX2016000219A (es) Compuestos neurotransmisores de dihidroxifenilo, composiciones y metodos.
AU2016356504A8 (en) 5-hydroxytryptamine 1B receptor-stimulating agent for enhancing in vivo engraftment potential
MX368870B (es) Uso de un antagonista de receptores de opioides con actividad kappa y vortioxetina para el tratamiento de trastorno depresivo con características melancólicas.
NZ721832A (en) Solid forms of tenofovir
IN2013MU02208A (hu)
SG11201608538UA (en) Compounds compositions and methods including thermally labile moieties
MX2016009665A (es) Composiciones y metodos para el tratamiento de la hemorragia cerebral.